Key management and advisory personnel include a former CEO of a major electron microscope manufacturer, the director of a university genome center, and successful entrepreneurs.
ZS
Genetics management is focused on understanding evolving
market needs, prioritizing technology development, and
maintaining intellectual property.
Management Team
William R. Glover III
Chairman,
President, Vice President of Research and Development
Thomas D. Abert
Vice President of Finance and Administration
Richard W. Smith
Director of Research and Development
ZSG management is also guided by an extensive network of
advisors. These advisors have provided substantial
improvement to the business model, market entry tactics and
financial strategies.
Board of Directors
William R. Glover, III –
Chairman
Thomas D. Abert –
Secretary, Treasurer
Jane E. Hager
Vahé A. Sarkissian
Scientific
Advisory Board
David C. Bell, PhD, FRMS
Harold Swerdlow, PhD
W. Kelley Thomas, PhD
Management
Team
William
R. Glover III
The founder of ZS Genetics, Mr. Glover combines scientific
vision, an engineer’s training, and a solid background in
risk-aversion project management, economics and recruiting.
Before inventing the technology behind ZS Genetics, he
worked as an energy industry economist, an energy industry
management consultant, and a small business strategy
consultant, running the US Middle Market Strategy Practice
for Cap Gemini Ernst & Young. Earlier, he worked for
Bechtel Corp., designing radiation safety systems for
commercial nuclear power plants. Mr. Glover holds a BS in
chemical engineering from CSU-Long Beach and an MBA from
the Darden School at the University of Virginia.
Thomas
D. Abert
ZS Genetic’s first investor, Mr. Abert offers a rich
background in technology management, helping engineers move
innovative technologies into commercial markets, and
experience working with start-ups and finance. Highlights
include helping launch and grow Hifi.com, a start-up
venture for Cambridge SoundWorks, and helping PC Connection
launch and manage their online business and service center.
Early technology management experience was at AT&T,
including Bell Labs, where he helped develop global
multimedia networks and applications. His career began in
finance, in both corporate finance and trading. Mr. Abert
holds an AS in computer science and a BA in music theory
from Keene State College, and an MBA from the Darden School
at the University of Virginia.
Richard W. Smith
Mr. Smith manages the various R&D projects, including
budgets, technical progress and the West Coast vendor
relationships, especially semiconductor chip designers and
fabricators. From 1997 through 2004, Rich held various
management positions within Intel Corporation, most
recently in Intel Capital where he was involved in the
incubation of several successful businesses. Prior to
Intel, Mr. Smith held positions with Cummins Engine Company
and General Electric and served in various Officer roles
with the United States Army. He also serves as a Director
of Raining Data Corporation (Ticker: RDTA). Mr. Smith holds
a BS in Civil Engineering from the United States Military
Academy and an MBA from the Darden School at the University
of Virginia.
Board of Directors
Vahé A. SarkissianFormer Chairman, President and CEO of FEI Co., the world's leader in electron microscope technology. Prior to that he was senior executive with a number of semiconductor and capital equipment companies, including president and CEO of two other publicly-traded technology companies, Metrologix Inc., and SVG Lithography Systems, the latter a subsidiary of Silicon Valley Group of which he also became president and COO. Previously he served as vice president of Data General Corp. responsible for the semiconductor and telecommunication products divisions, where he led a major telecommunications venture with Nippon Telephone and Telegraph. Prior to Data General Vahé was a senior executive at Advanced Micro Devices.
Frank
E. Ferguson
President of Curriculum Associates, Inc.
(www.CAInc.com).
Mr. Ferguson is an active investor and member of the board
or advisor for several other companies, including: EdTech
Networks, Way Systems, Net Clarity, and DigitalBrix. He has
been president of several corporations, including Bose
Corporation for seven years, and Curriculum Associates, of
which he is a founder and it's President.
Jane
E. Hager
Founder, CEO, President of Prescott Investment Corp.,
President of Pinnacle Mountain Partners; Managing Member,
Angelfish Investments and Gulf Coast Investment Partners.
Ms. Hager has extensive experience in the founding and
management of public life sciences companies, including:
IGI, Novavax, and National Medical Care. She also has
extensive banking industry experience, including: founding
director for Centrix Bank and Trust (where she is head of
the Audit Committee), and director for Fleet Bank – New
Hampshire.
Scientific Advisory Board
David C. Bell, PhD, FRMS
Dr. Bell, is Lecturer in Applied Physics at the School of Engineering and
Applied Sciences at Harvard University. He also manages the imaging and
analysis facility at the Center for Nanoscale Systems which is part of the
Faculty of Arts and Sciences at Harvard. His current research interests
include; nanocomposites and nanowire materials. Investigating new mechanisms
for materials imaging and analysis with charged particle beams, electron
aberration determination, correction and the measurements and the
application with analytical microscopy methods for advanced and adaptive
correlative microscopy. He is widely published in journals and books and
holds several patents. Dr. Bell did his postdoctoral studies at MIT, and
received his Ph.D. from the University of Melbourne, Australia. He is a
member of the Microscopy Society of America and Fellow of the Royal
Microscopical Society, U.K.
Michael
F. Holick, MD, PhD
Dr. Holick is a renowned endocrinologist and professor
of medicine, biophysics and physiology at Boston
University School of Medicine. He has extensively
researched the sources and effects of Vitamin D on the
body. In addition to his many Academic and Hospital
appointments, Dr. Holick also has an extensive background
with life sciences companies, including: A&D
Bioscience, Strakan USA, IGI, Manhattan Pharmaceuticals,
and Bridge to Life. He is the inventor of 42
approved or pending patents, holds numerous other awards,
and has an extensive number of publications.
More information is available on Dr. Holick at www.UVAdvantage.org.
Harold Swerdlow, PhD
Dr. Swerdlow is the Head of Sequencing Technology at the Wellcome Trust
Sanger Institute (Sanger Centre). In this capacity, he is responsible for
next-generation DNA sequencing instrumentation - technology assessment,
acquisition and development. He also manages one of the largest DNA
sequencing production facilities in the world, currently generating more
than 500 billion bases of DNA sequence per week. Previously, he was the
Chief Technology Officer at Dolomite Ltd., a DTI-funded microfabrication and
microfluidics business, performing R&D project management and business
development. Before Dolomite, he was the Senior Director of Research at
Solexa Ltd. (now Illumina, Inc.), responsible for developing the technology
that is now the most widely used for next-generation DNA sequencing. Before
Solexa, he spent many years in academic research, managing various
technology development projects. He has a long-standing interest in using
miniaturization and microfluidic technology to solve problems in molecular
biology and genome science.
W.
Kelley Thomas, PhD
Dr.
Thomas is the Hubbard Professor in Genomics and Director of the
Hubbard Center for Genome Studies, University of New
Hampshire. Dr. Thomas has a long academic career in
genomics at the University of Missouri – Kansas City, and
University of California – Berkeley, in addition to the
University of New Hampshire. He has over 40 publications.
More information on Dr. Thomas is available at hcgs.unh.edu/staff/